Epsilon Healthcare Limited

As of December 31, 2025, Epsilon Healthcare Limited carries a market capitalization of 542,968.25, placing it among publicly traded companies globally. Its enterprise value stands at 7.29M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, Epsilon Healthcare Limited has 379.10M shares outstanding.

These figures are as of December 31, 2025. The price-to-sales ratio is 0.09, and the price-to-book ratio stands at 0.43.

These figures are as of December 31, 2025. The EV/Sales ratio of 1.16 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 7.29M versus a market cap of 542,968.25, with the gap driven by net debt and cash on the balance sheet.

As of December 31, 2025, Epsilon Healthcare Limited maintains a current ratio of 1.17, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 541.30, indicating elevated leverage, while an interest coverage ratio of -2.24 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended December 31, 2025. Return on assets (ROA) is negative at -9.03, reflecting losses generated across the asset base. Inventory turnover of 4.19 indicates how many times Epsilon Healthcare Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended December 31, 2025, Epsilon Healthcare Limited recorded an income tax benefit of -645,350.11 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -1.50M and -853,416.33 in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on July 9, 2026, Epsilon Healthcare Limited's stock has gained approximately 614.29% over the past 52 weeks.

Over the twelve months ended December 31, 2025, Epsilon Healthcare Limited generated 6.27M in revenue and converted that into -853,416.33 in net income, yielding earnings per share of 0.00. EBITDA reached -1.35M, while operating income came in at -1.59M.

As of December 31, 2025, Epsilon Healthcare Limited holds 162,113.34 in cash and equivalents against 6.91M in total debt, resulting in a net debt position of 3.10M. Total book value stands at 1.28M, with working capital of 510,655.50 providing operational flexibility.

These figures cover the twelve months ended December 31, 2025.

Over the twelve months ended December 31, 2025, Epsilon Healthcare Limited posted a gross margin of 61.31, reflecting its pricing power and cost economics. The operating margin of -25.31 and net profit margin of -13.61 provide insight into operational efficiency.

These figures cover the twelve months ended December 31, 2025. Total shareholder yield reaches 551.05, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Epsilon Healthcare Limited shareholders.

As of December 31, 2025, Epsilon Healthcare Limited has an Altman Z-Score of -3.82, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.